Work

The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial

Year: 2015

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Vaccine

DOI: 10.1016/j.vaccine.2015.05.036

Authors: Hennie Geldenhuys, Helen Mearns, David J.C. Miles, Michele Tameris, David Hokey, Zhongkai Shi, Sean Bennett, Peter Andersen, Ingrid Kromann, Søren T. Hoff, Willem A. Hanekom, Hassan Mahomed, Mark Hatherill, Thomas J. Scriba, Michele van Rooyen, J. Bruce McClain, Robert Ryall, Guy de Bruyn

Institutions: University of Cape Town, South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Aeras, Gilead Sciences (United States), Statens Serum Institut

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Aeras Global Tuberculosis Vaccine Foundation, Wellcome Trust

Award: G76681233

OpenAlex ID: W631768487

FWCI: 9.861

Cites: 18

Cited by: 81

Related to: 10